ストックスクリーナーアプリを入手
15.53
1.97%
0.315
前日終値:
$15.21
開ける：
$15.27
24時間の取引高:
121.15K
Relative Volume:
0.37
時価総額：
$560.94M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-1.40%
1か月 パフォーマンス:
-13.40%
6か月 パフォーマンス:
-33.26%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$15.15
$15.89
1週間の範囲:
$15.15
$16.04
52週間の値動き範囲:
$10.01
$32.75
Ceribell Inc Stock (CBLL) Company Profile
CBLL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
15.52 | 592.02M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
125.19 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.62 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
394.53 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.47 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.31 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-24 | 開始されました | BTIG Research | Buy |
| 2025-04-04 | 開始されました | Ladenburg Thalmann | Buy |
| 2024-11-05 | 開始されました | BofA Securities | Buy |
| 2024-11-05 | 開始されました | Canaccord Genuity | Buy |
| 2024-11-05 | 開始されました | JP Morgan | Overweight |
| 2024-11-05 | 開始されました | TD Cowen | Buy |
| 2024-11-05 | 開始されました | William Blair | Outperform |
すべてを表示
Ceribell Inc (CBLL) 最新ニュース
What drives CeriBell Inc. stock priceRemarkable growth - jammulinksnews.com
What analysts say about CeriBell Inc. stockExceptional gains - PrintWeekIndia
CeriBell Inc. Stock Analysis and ForecastExceptional risk-adjusted gains - jammulinksnews.com
Is CeriBell Inc. a good long term investmentExplosive capital gains - Autocar Professional
How CeriBell Inc. stock performs during market volatilityReturn Optimized Trade Insights - Newser
Brokerages Set CeriBell, Inc. (NASDAQ:CBLL) Price Target at $32.14 - Defense World
What makes CeriBell Inc. stock price move sharplyFast Gains With Reduced Risk - Newser
Why CeriBell Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
CeriBell shares drop 38% following InvestingPro’s overvaluation warning By Investing.com - Investing.com South Africa
Ceribell sues Natus Medical for patent infringement - MSN
Ceribell, Inc.’s Strategic Positioning and Patent Strength Justify Buy Rating - TipRanks
Ceribell (CBLL) CEO Chao sells $442,500 in stock By Investing.com - Investing.com South Africa
Ceribell (CBLL) CEO Chao sells $442,500 in stock - Investing.com
Ceribell files patent infringement complaints against Natus Medical By Investing.com - Investing.com South Africa
Ceribell's IP Offense: How Legal Aggression Could Spark a Neurotech Breakout - AInvest
Ceribell files patent infringement complaints against Natus Medical - Investing.com Australia
Ceribell's Legal Offense and Pediatric Breakthrough: A Strategic Double Play for Market Dominance - AInvest
Ceribell Files Patent Infringement Complaints Against Natus - TipRanks
CeriBell Files Patent Infringement Complaints Against Natus Medical - MarketScreener
Ceribell sues Natus Medical for patent infringement (CBLL) - Seeking Alpha
Ceribell files complaints against Natus Medical, alleges patent infringement - TipRanks
CeriBell, Inc. Files Patent Infringement Complaints Against Natus Medical Incorporated - Nasdaq
Ceribell Files Complaints Against Natus Medical Incorporated with the U.S. International Trade Commission and Federal Court in Delaware - GlobeNewswire
Ceribell Hits Competitor With Patent Lawsuit Over Wearable EEG - Bloomberg Law News
Rhumbline Advisers Buys 3,276 Shares of CeriBell, Inc. (NASDAQ:CBLL) - Defense World
CeriBell a new buy at BTIG on growth in EEG monitoring system - MSN
Ceribell initiated with a Buy at BTIG - TipRanks
BTIG initiates Ceribell stock with Buy rating on AI-driven EEG system - Investing.com Canada
Transforming Neurological Care: Ceribell (CBLL) - Insider Monkey
Ceribell's Insider Sale: A Strategic Move or Red Flag? Decoding the Opportunity in Biomedical Innovation - AInvest
Ceribell Extends Exclusive License with Stanford University - TipRanks
Ceribell Inc (CBLL) 財務データ
Ceribell Inc (CBLL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Ceribell Inc (CBLL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Chao Xingjuan | President and CEO |
Jul 07 '25 |
Sale |
17.70 |
25,000 |
442,500 |
776,022 |
1.21%
0.22%
大文字化:
|
ボリューム (24 時間):